glp 1 bcbs coverage Rising Costs Lead Insurers to Drop Weight Loss Drug Coverage, Further Increasing Patient Burden Navigating GLP-1 Meds Coverage Loss

Doc is no help, doesn't think that the jab is the cause

Glucagon-like peptide-1 receptor agonists (GLP-1RAs) have rapidly become central to the treatment of type 2 diabetes and obesity

Construction of Escherichia coli K-12 in-frame, single-gene knockout mutants: the Keio collection

Friedmans patients have benefited from these compounded GLP-1s which are available in syringes allowing individual dosing that is not possible with the commercial medicines

The bioavailability of 25(OH)VD 3 in the blood in response to dietary VD intake varies significantly among individual subjects and is dependent on the status of the VD metabolism genes 14,15,16,17